MedElevator Войти в исследования
← Поиск публикаций

DOI 10.17219/acem/112605

Медицинская библиотека · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2020

Non-Hodgkin lymphoma after liver and kidney transplantation in children. Experience from one center.

Dembowska-Bagińska Bożenna, Wakulińska Anna, Daniluk Iwona, Teisseyre Joanna, Jankowska Irena, Czubkowski Piotr, Grenda Ryszard, Jarmużek Wioletta, Grajkowska Wiesława, Małdyk Jagoda, Kaliciński Piotr

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Post-transplantation lymphoproliferative disorder (PTLD) is a complication of organ transplantation and a life-threatening condition. Children who underwent organ transplantation are at risk of developing lymphoproliferative disorders and, among them, non-Hodgkin lymphoma (NHL) is the most serious.

OBJECTIVES

The objective of this study was to describe the clinical course of NHL after liver and kidney transplantation.

MATERIAL AND

METHODS

Retrospective analysis of medical records of children who underwent liver/kidney transplantation and developed NHL.

RESULTS

Nine children were identified, all girls, 6 after liver and 3 after kidney transplantations. Age at transplantation ranged from 1 year to 13 years (median: 4 years), while age at lymphoma diagnosis from 4 to 17 years (median: 12 years). Time from transplantation to lymphoma diagnosis ranged from 7 months to 12 years (median: 9 years). All but 1 patient developed mature B-cell lymphoma, 4 children - diffuse large B-cell lymphoma (DLBCL), 2 children - Burkitt's lymphoma, 1 child - mature B-cell leukemia, 1 child - Burkitt-like lymphoma, while 1 patient was diagnosed with T-cell lymphoblastic lymphoma. High levels of Epstein-Barr virus (EBV) DNA were found in blood of 3 patients, and EBV in tissue samples was detected in 4 patients. Six patients presented with stage III and 2 with stage IV disease. Two patients had graft involvement. Three children received chemotherapy according to R-CHOP, 3 LMB protocol (2 with addition of rituximab), while 1 received CHOP and 5 courses of COP. T-cell lymphoma patient was treated with Euro-LB protocol. Six out of 8 treated patients are alive with a median follow-up of 6 years. Two children died from disease progression during treatment and 1 from cerebral herniation before starting therapy. All patients experienced at least 1 toxic episode of grade 3 and 4 according to Common Toxicity Criteria Adverse Event (CTCAE). Complications of chemotherapy were manageable and there were no transplanted organ failures.

CONCLUSIONS

Our study provides further data on the treatment and outcome of monomorphic PTLD and indicates that it is feasible to treat solid organ recipients with multiagent chemotherapy.

Для цитирования: Dembowska-Bagińska Bożenna, Wakulińska Anna, Daniluk Iwona, Teisseyre Joanna, Jankowska Irena, Czubkowski Piotr, Grenda Ryszard, Jarmużek Wioletta, Grajkowska Wiesława, Małdyk Jagoda, Kaliciński Piotr. Non-Hodgkin lymphoma after liver and kidney transplantation in children. Experience from one center.. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2020. DOI: 10.17219/acem/112605.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.